Cargando…
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
BACKGROUND: Evidences support social inequalities in cancer survival. Studies on hematological malignancies, and more specifically Acute Myeloid Leukemia (AML), are sparser. Our study assessed: 1/ the influence of patients’ socioeconomic position on survival, 2/ the role of treatment in this relatio...
Autores principales: | Berger, Eloïse, Delpierre, Cyrille, Despas, Fabien, Bertoli, Sarah, Bérard, Emilie, Bombarde, Oriane, Bories, Pierre, Sarry, Audrey, Laurent, Guy, Récher, Christian, Lamy, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729078/ https://www.ncbi.nlm.nih.gov/pubmed/31488077 http://dx.doi.org/10.1186/s12885-019-6093-3 |
Ejemplares similares
-
Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience
por: Bertoli, Sarah, et al.
Publicado: (2019) -
Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
por: Bories, Pierre, et al.
Publicado: (2018) -
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
por: Dumas, Pierre-Yves, et al.
Publicado: (2017) -
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival
por: Borel, Cécile, et al.
Publicado: (2015) -
CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
por: Vergez, François, et al.
Publicado: (2020)